Biomotion Sciences (SLXN) Balance Sheet
SLXN balance sheet, 2025
December 31, 2025 · U.S. dollars$7.2M assets = $4.6M liabilities + $2.6M equity
Both columns are drawn to the same scale: what SLXN owns equals what it owes plus shareholders’ equity. Hover a block for its value.
SLXN financial health
Descriptive bands, not a rating. Fiscal 2025.
SLXN balance sheet trends, 2020–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $129,3992020 | $7.2M2025 | +123.5%/yr | |
| Total liabilities | $299,3902020 | $4.6M2025 | +72.8%/yr | |
| Shareholders’ equity | −$169,9902020 | $2.6M2025 | — | |
| Cash & short-term investments | $51,7012020 | $6.0M2025 | +158.7%/yr | |
| Total debt | $271,0002022 | $468,0002025 | +20.0%/yr | |
| Net cash (debt) | $8.0M2022 | $5.5M2025 | −$2.5M | |
| Working capital | $22,3012020 | $3.9M2025 | +$3.9M | |
| Current ratio | 1.762020 | 2.412025 | +0.65 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
SLXN assets
SLXN liabilities and equity
SLXN debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
SLXN balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & short-term investments | $6.0M | $1.2M | $4.6M | $8.3M | $38,944 | $51,701 |
| Cash & equivalents | $6.0M | $1.2M | $4.6M | $8.3M | $38,944 | $51,701 |
| Short-term investments | — | $35,000 | — | — | — | — |
| Receivables | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $646,000 | $1.1M | $384,000 | $580,000 | $368,853 | $0 |
| Total current assets | $6.6M | $2.2M | $5.0M | $8.8M | $407,797 | $51,701 |
| Property, plant & equipment (net) | $437,000 | $560,000 | $247,000 | $464,000 | $0 | $0 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $141,000 | $53,000 | $30,000 | $30,000 | $115.0M | $77,698 |
| Total assets | $7.2M | $2.9M | $5.3M | $9.3M | $115.4M | $129,399 |
| Liabilities | ||||||
| Accounts payable | $787,000 | $929,000 | $319,000 | $240,000 | — | — |
| Short-term debt | $182,000 | $1.2M | $112,000 | $115,000 | — | — |
| Total current liabilities | $2.8M | $3.5M | $2.2M | $1.6M | $348,576 | $29,400 |
| Long-term debt | $1.6M | $3.0M | $0 | $0 | $0 | $0 |
| Lease obligations | $468,000 | $526,000 | $171,000 | $271,000 | — | — |
| Other long-term liabilities | $286,000 | $368,000 | $15.1M | $14.8M | $160,340 | $269,990 |
| Total liabilities | $4.6M | $6.9M | $17.3M | $16.4M | $508,916 | $299,390 |
| Shareholders' equity | ||||||
| Common stock & paid-in capital | $42,000 | $2,000 | $1,000 | $1,000 | $115.0M | $298 |
| Retained earnings (deficit) | −$55.2M | −$43.3M | −$26.8M | −$21.9M | −$951,078 | −$195,860 |
| Minority interest | — | $0 | $3.4M | $3.6M | — | — |
| Total shareholders' equity | $2.6M | −$4.0M | −$15.5M | −$10.7M | $114.9M | −$169,990 |
| Key figures | ||||||
| Total debt | $468,000 | $4.5M | $171,000 | $271,000 | — | — |
| Net cash (debt) | $5.5M | −$3.3M | $4.4M | $8.0M | — | — |
| Working capital | $3.9M | −$1.3M | $2.8M | $7.2M | $59,221 | $22,301 |
| Tangible book value | $2.6M | −$4.0M | −$15.5M | −$10.7M | $114.9M | −$169,990 |
| Current ratio | 2.41 | 0.64 | 2.27 | 5.49 | 1.17 | 1.76 |
| Quick ratio | 2.17 | 0.34 | 2.09 | 5.13 | 0.11 | 1.76 |
| Debt / equity | 0.18 | — | — | — | — | — |
| Equity / assets | 36.1% | −139.3% | −294.4% | −114.3% | 99.6% | −131.4% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $2.2M | $2.4M | $6.0M | $9.2M | $3.5M | $6.2M | $1.2M | $2.0M | $1.7M | $2.8M | $4.6M | $5.6M |
| Cash & equivalents | $2.2M | $2.4M | $6.0M | $9.2M | $3.5M | $6.2M | $1.2M | $2.0M | $1.7M | $2.8M | $4.6M | $58,238 |
| Short-term investments | — | — | — | — | — | — | $35,000 | — | — | — | $5.7M | $5.6M |
| Receivables | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $1.5M | $1.7M | $646,000 | $1.8M | $1.8M | $1.6M | $1.1M | $1.1M | $618,000 | $558,000 | $384,000 | $28,080 |
| Total current assets | $3.7M | $4.1M | $6.6M | $11.1M | $5.2M | $7.7M | $2.2M | $3.0M | $2.3M | $3.3M | $5.0M | $5.7M |
| Property, plant & equipment (net) | $368,000 | $403,000 | $437,000 | $468,000 | $502,000 | $534,000 | $560,000 | $35,000 | $180,000 | $216,000 | $247,000 | $0 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $137,000 | $134,000 | $141,000 | $91,000 | $58,000 | $52,000 | $53,000 | $5,000 | $30,000 | $30,000 | $30,000 | $0 |
| Total assets | $4.2M | $4.6M | $7.2M | $11.6M | $5.8M | $8.3M | $2.9M | $3.1M | $2.5M | $3.6M | $5.3M | $5.7M |
| Liabilities | ||||||||||||
| Accounts payable | $1.2M | $912,000 | $787,000 | $946,000 | $692,000 | $722,000 | $929,000 | $799,000 | $281,000 | $244,000 | $319,000 | — |
| Short-term debt | $1.2M | $185,000 | $182,000 | $174,000 | $171,000 | $155,000 | $1.2M | $229,000 | $108,000 | $110,000 | $112,000 | $2.5M |
| Total current liabilities | $4.0M | $4.1M | $2.8M | $2.8M | $2.1M | $2.4M | $3.5M | $3.6M | $2.4M | $1.9M | $2.2M | $2.5M |
| Long-term debt | $0 | $0 | $1.6M | $1.5M | $3.2M | $3.0M | $3.0M | $4.1M | $0 | $0 | $0 | $0 |
| Lease obligations | $425,000 | $436,000 | $468,000 | $485,000 | $508,000 | $489,000 | $526,000 | $0 | $116,000 | $144,000 | $171,000 | — |
| Other long-term liabilities | $226,000 | $251,000 | $286,000 | $311,000 | $337,000 | $334,000 | $368,000 | $0 | $15.1M | $15.1M | $15.1M | $9,405 |
| Total liabilities | $4.2M | $4.3M | $4.6M | $4.6M | $5.7M | $5.7M | $6.9M | $7.7M | $17.4M | $17.0M | $17.3M | $2.5M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $160,000 | $46,000 | $42,000 | $42,000 | $8,000 | $8,000 | $2,000 | $1,000 | $1,000 | $1,000 | $1,000 | $5.6M |
| Retained earnings (deficit) | −$61.5M | −$57.9M | −$55.2M | −$50.8M | −$47.5M | −$45.0M | −$43.3M | −$41.6M | −$29.7M | −$28.2M | −$26.8M | −$2.4M |
| Total shareholders' equity | $44,000 | $291,000 | $2.6M | $7.0M | $120,000 | $2.6M | −$4.0M | −$4.6M | −$18.3M | −$16.8M | −$15.5M | $3.1M |
| Key figures | ||||||||||||
| Total debt | $1.4M | $436,000 | $468,000 | $485,000 | $3.7M | $3.5M | $4.5M | $4.3M | $116,000 | $144,000 | $171,000 | $2.5M |
| Net cash (debt) | $819,000 | $2.0M | $5.5M | $8.8M | −$232,000 | $2.7M | −$3.3M | −$2.3M | $1.6M | $2.6M | $4.4M | $3.2M |
| Working capital | −$235,000 | $5,000 | $3.9M | $8.3M | $3.1M | $5.3M | −$1.3M | −$536,000 | −$49,000 | $1.4M | $2.8M | $3.1M |
| Tangible book value | $44,000 | $291,000 | $2.6M | $7.0M | $120,000 | $2.6M | −$4.0M | −$4.6M | −$18.3M | −$16.8M | −$15.5M | $3.1M |
| Current ratio | 0.94 | 1.00 | 2.41 | 3.97 | 2.44 | 3.22 | 0.64 | 0.85 | 0.98 | 1.72 | 2.27 | 2.25 |
| Quick ratio | 0.56 | 0.59 | 2.17 | 3.32 | 1.61 | 2.57 | 0.34 | 0.55 | 0.72 | 1.43 | 2.09 | 2.23 |
| Debt / equity | 32.05 | 1.50 | 0.18 | 0.07 | 30.82 | 1.35 | — | — | — | — | — | 0.79 |
| Equity / assets | 1.0% | 6.3% | 36.1% | 60.1% | 2.1% | 31.1% | −139.3% | −148.3% | −723.0% | −469.1% | −294.4% | 55.3% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 17, 2026); data from EODHD.
SLXN financial position
At the end of fiscal 2025 (December 31, 2025), Biomotion Sciences had total assets of $7.2 million (up 152.0% from a year earlier), total liabilities of $4.6 million and shareholders' equity of $2.6 million. It held $6.0 million in cash and short-term investments against $0.5 million of debt, a net cash position of $5.5 million. Its current ratio was 2.41. In the latest quarter (ended June 30, 2026) total assets were $4.2 million and equity $0.0 million.
Related: SLXN income statement, SLXN cash flow statement, SLXN key metrics. See the SLXN stock overview for the latest quote and news.
SLXN balance sheet FAQ
What are Biomotion Sciences's total assets?
Biomotion Sciences reported total assets of $7.2 million at the end of fiscal 2025 (December 31, 2025), compared with $2.9 million a year earlier.
How much debt does Biomotion Sciences have?
Biomotion Sciences had $0.5 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.18.
How much cash does Biomotion Sciences have?
Biomotion Sciences held $6.0 million in cash and short-term investments at the end of fiscal 2025; with $0.5 million of debt that is net cash of $5.5 million.
What is Biomotion Sciences's book value?
Biomotion Sciences's shareholders' equity (book value) was $2.6 million at the end of fiscal 2025.
What is Biomotion Sciences's current ratio?
Biomotion Sciences had current assets of $6.6 million and current liabilities of $2.8 million, a current ratio of 2.41 (it can cover its short-term obligations).